Skip to main content

Table 4 Summary ORs of asthma and early life vitamin D intake (highest versus lowest category) in cohort studies, according to selected subgroups

From: Early life vitamin D status and asthma and wheeze: a systematic review and meta-analysis

Age at outcome assessment >5y

Age at outcome assessment ≤5y

Subgroup

Studies (Ref. no.)

No. of studies

OR (95% CI)

I2

Studies (Ref. no.)

No. of studies

OR (95% CI)

I2

Window of exposure assessment

 During pregnancy (mother)

[50, 57]

2

1.21 [0.90, 1.62]

64%

[49, 53, 55, 56]

4

0.89 [0.77, 1.04]

68%

 During infancy

[52]

1

0.74 [0.56, 0.96]

–

[52, 54]

2

0.95 [0.85, 1.06]

27%

Period of outcome assessment

 At an end point (e.g. at age 1y)

[50, 52, 57]

3

0.90 [0.56, 1.45]

77%

[54]

1

0.60 [0.27, 1.31]

–

 Up to an end point (e.g. by age 1y)

[50]

1

0.60 [0.32, 1.11]

–

[49, 52, 53, 55, 56]

5

0.94 [0.86, 1.02]

60%

Latitude

 Tropics or subtropics (more intense UVR) (≤40°N/S)

–

–

–

–

[54]

1

0.60 [0.27, 1.31]

–

 Temperate (40–66.5°N/S)

[50, 52, 57]

3

0.90 [0.56, 1.45]

77%

[49, 52, 53, 55, 56]

5

0.94 [0.86, 1.02]

60%

Region

 Europe

[50, 52, 57]

3

0.90 [0.56, 1.45]

77%

[49, 52, 53, 56]

4

0.96 [0.88, 1.05]

47%

 USA/Canada

    

[55]

1

0.65 [0.46, 0.93]

–

 Asia

    

[54]

1

0.60 [0.27, 1.31]

–

Adjusted for family history of atopy

 No

[57]

1

1.33 [0.97, 1.82]

–

[55]

1

0.65 [0.46, 0.93]

–

 Yes

[50, 52]

2

0.73 [0.56, 0.94]

0%

[49, 52,53,54, 56]

5

0.95 [0.87, 1.04]

43%

Adjusted for seasonality

 No

[57]

1

1.33 [0.97, 1.82]

–

[53,54,55,56]

4

0.64 [0.48, 0.86]

29%

 Yes

[50, 52]

2

0.73 [0.56, 0.94]

0%

[49, 52]

2

0.97 [0.88, 1.06]

0%

Adjusted for smoking statues

 No

[57]

1

1.33 [0.97, 1.82]

–

[56]

1

3.16 [0.61, 16.32]

–

 Yes

[50, 52]

2

0.73 [0.56, 0.94]

0%

[49, 52,53,54,55]

5

0.93 [0.85, 1.01]

56%

Outcome assessment

 Maternal report of doctor diagnosed or medication only

[50]

1

0.60 [0.32, 1.11]

–

[52, 53]

2

0.94 [0.85, 1.05]

71%

 Maternal report of doctor diagnosed plus medication and/or wheeze symptom

[50, 52, 57]

3

0.90 [0.56, 1.45]

77%

[49, 55]

2

0.82 [0.55, 1.24]

77%

 Doctor diagnosed or medical review

–

–

–

–

[54]

1

0.60 [0.27, 1.31]

–

 Based on ISAAC questionnaire

–

–

–

–

[56]

1

3.16 [0.61, 16.32]

–

Risk of bias

 Moderate

[52, 57]

2

0.98 [0.55, 1.75]

87%

[49, 52, 54, 56]

4

0.96 [0.88, 1.06]

14%

 High

[50]

1

0.63 [0.28, 1.44]

–

[53, 55]

2

0.61 [0.45, 0.84]

0%

Overall

[50, 52, 57]

3

0.90 [0.56, 1.45]

77%

[49, 52,53,54,55,56]

6

0.93 [0.85, 1.02]

56%

  1. ISAAC: The International Study of Asthma and Allergies in Children; LC-MS/MS: liquid chromatography-tandem mass spectrometry; UVR: ultraviolet radiation